Johnson & Johnson (JNJ)
191.08
+1.39 (0.73%)
NYSE · Last Trade: Oct 9th, 6:56 PM EDT
New York, NY – October 9, 2025 – Pfizer Inc. (NYSE:PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of 2025. This latest payout marks a significant milestone: the company's 348th consecutive quarterly dividend. The unwavering consistency of
Via MarketMinute · October 9, 2025
The ongoing government shutdown has plunged financial markets into a state of heightened uncertainty, as the vital flow of economic data—the lifeblood of informed decision-making—grinds to a halt. With key agencies like the Bureau of Labor Statistics (BLS), Bureau of Economic Analysis (BEA), and the Census Bureau ceasing
Via MarketMinute · October 9, 2025
New York, NY – October 9, 2025 – Pfizer Inc. (NYSE: PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of 2025. This payment marks a significant milestone as the company's 348th consecutive quarterly dividend, a testament to its
Via MarketMinute · October 9, 2025
The Dow Jones Industrial Average (DJIA) experienced a notable slide today, October 9, 2025, as a confluence of a U.S. government shutdown, mounting economic concerns, and specific corporate disappointments sent ripples of apprehension through the financial markets. This downturn signals a renewed period of volatility, challenging investor confidence and
Via MarketMinute · October 9, 2025
In a series of recent and increasingly pointed warnings, some of America's most influential financial leaders are cautioning investors to prepare for a significant stock market downturn within the coming years. This chorus of cautionary outlooks, spearheaded by figures such as Jamie Dimon of JPMorgan Chase, Larry Fink of BlackRock,
Via MarketMinute · October 9, 2025
A significant surge in capital flowing into short-bias Exchange-Traded Funds (ETFs) has sent a clear signal through the financial markets: investor sentiment is shifting towards caution and a potential stock market pullback. This notable trend, particularly pronounced in recent weeks, suggests that a growing number of investors are actively positioning
Via MarketMinute · October 9, 2025
The relentless ascent of the U.S. stock market has hit a significant speed bump, as both the S&P 500 and Nasdaq Composite have retreated from their recent record highs. This pullback, occurring after weeks of robust gains, signals a period of reassessment for investors grappling with a confluence
Via MarketMinute · October 9, 2025
As October 2025 unfolds, a palpable tension hangs over global financial markets. Despite record highs in major indices like the Nasdaq 100 (NASDAQ: NDX) and the FTSE 100 (LSE: UKX), a growing chorus of analysts and economists are sounding the alarm, warning that the stock market is exhibiting classic signs
Via MarketMinute · October 9, 2025
The Federal Reserve has embarked on a delicate balancing act, initiating interest rate cuts in 2025 to bolster a softening labor market while grappling with persistent inflation concerns among some of its most influential officials. As of October 8, 2025, financial markets are closely scrutinizing every statement and data point,
Via MarketMinute · October 8, 2025
FDA approves Johnson & Johnson's Simponi for children with moderate to severe ulcerative colitis, supported by positive Phase 3 trial results.
Via Benzinga · October 8, 2025
One of these stocks lost about a quarter of its value in a single month.
Via The Motley Fool · October 8, 2025
Pfizer stock is moving higher after being named part of the TrumpRx platform; but two other biopharma companies may offer better long-term growth potential
Via MarketBeat · October 8, 2025
These two market leaders have increased their dividends for a combined 115 years.
Via The Motley Fool · October 7, 2025
On a day where the broader S&P 500 and Nasdaq Composite indices soared to new all-time record highs, the S&P 500 Healthcare sector presented a compelling, albeit nuanced, narrative of market leadership and resilience. While the overall market sentiment exuded robust optimism, the healthcare sector itself showcased a
Via MarketMinute · October 7, 2025
As legislation in Congress heats up to ban elected officials from buying and selling stocks, several members have violated the STOCK Act in 2025, failing to disclose their transactions in a timely fashion.
Via Benzinga · October 7, 2025
According to a Reuters report, a Los Angeles Jury has ordered the company to pay $16 million in compensatory damages and $950 million in punitive damages.
Via Stocktwits · October 7, 2025
The US market session of Tuesday has yet to be opened, let's have a look at the top S&P500 gainers and losers in the pre-market session today.
Via Chartmill · October 7, 2025
The surgical robotics pioneer could cement its leading position for years to come.
Via The Motley Fool · October 7, 2025
Washington D.C., October 6, 2025 – The American labor market appears to have hit a significant speed bump, with Moody's Analytics reporting "essentially no job growth" for the U.S. in September 2025. This concerning assessment comes at a critical juncture for the economy, compounded by an ongoing federal government
Via MarketMinute · October 6, 2025
While Kenvue's Tylenol has attracted intense political pressure, speculators are determined to make KVUE stock great again.
Via Benzinga · October 6, 2025
Trump’s drug price plan drove a Pfizer rally, leaves Eli Lilly buffered by U.S. investments, and could boost JNJ if it secures similar tariff relief.
Via MarketBeat · October 6, 2025
The financial markets, as of October 4, 2025, continue to be characterized by a significant degree of volatility, presenting both opportunities and perilous traps for investors. In such an environment, one of the most dreaded outcomes is becoming a "bag holder" – an investor left clinging to a security that has
Via MarketMinute · October 4, 2025
The U.S. financial markets are currently presenting a perplexing paradox. As of October 4, 2025, both the S&P 500 and Dow Jones Industrial Average (DJIA) have surged to unprecedented record highs, exhibiting remarkable resilience. This bullish momentum, however, unfolds against a backdrop of significant political turmoil: the federal
Via MarketMinute · October 4, 2025
The United States government is currently in the throes of a shutdown, commencing at 12:01 a.m. EDT on October 1, 2025, after a congressional impasse prevented the passage of appropriations legislation for the 2026 fiscal year. This fiscal stalemate has immediately plunged global financial markets into a state
Via MarketMinute · October 3, 2025